Announcements
Announcement on behalf of Amaran of not Distributing Dividends of 2023
1.Date of the board of directors resolution:2024/04/12 2.Type and monetary amount of dividend distribution:The Board of Directors of Amaran resolved not to distribute dividends of 2023. 3.Any other matters that …
Announcement on behalf of Amaran that the BOD resolved to convene the 2024 Annual General Shareholders’ Meeting
1.Date of the board of directors resolution:2024/04/12 2.General shareholders’ meeting date:2024/05/27 3.General shareholders’ meeting location: 5th Floor, No.19, Shengyi 5th Rd., Zhubei City, Hsinchu County 4.Cause for convening the meeting …
Announcement on behalf of OBIGEN of not Distributing Dividends of 2023
1.Date of the board of directors resolution:2024/03/20 2.Type and monetary amount of dividend distribution:The Board of Directors of OBIGEN resolved not to distribute dividends of 2023. 3.Any other matters that …
Announcement on behalf of OBIGEN that the BOD resolved to issue 2024 employee stock options and the subscription rules.
1.Date of the board of directors resolution:2024/03/20 2.Issue period:Issued within two years since the date of approval of Board of Directors; issued at once or in tranches depending on actual …
Announcement on behalf of OBIGEN that the BOD resolved to convene the 2024 Annual General Shareholders’ Meeting
1.Date of the board of directors resolution:2024/03/20 2.General shareholders’ meeting date:2024/06/19 3.General shareholders’ meeting location: Conference room of OBI Pharma, Inc. (6th Floor, No. 508, Section 7, Zhongxiao East Road, …
Announcement of BOD’s resolution to lift the non-competition restrictions for managerial officers
1.Date of the board of directors resolution:2024/03/11 2.Name and title of the managerial officer with permission to engage in competitive conduct: Heidi Wang/ CEO Ming-Tain Lai/ Chief Scientific Officer Colin …
Announcement of 2023 Consolidated Financial Statements were approved by the Board of Directors
1.Date of the board of directors submitted or approved:2024/03/11 2.Date of the audit committee approved:2024/03/08 3.Start and end dates of financial reports or unaudited financial information of the reporting period(XXXX/XX/XX~XXXX/XX/XX): …
The Company’s Board of Directors resolved to convene the 2024 Annual General Shareholders’ Meeting
1.Date of the board of directors resolution:2024/03/11 2.General shareholders’ meeting date:2024/06/17 3.General shareholders’ meeting location: Masterlink Securities Education and Training Center (11F., No.97, Sec. 2, Dunhua S. Rd., Taipei City) …
Announcement of not Distributing Dividends in 2023
1.Date of the board of directors resolution:2024/03/11 2.Year or quarter which dividends belong to :2023 3.Period which dividends belong to:2023/1/1 to 2023/12/31 4.Appropriations of earnings in cash dividends to shareholders …
OBI announces the termination of OBI-3424-001 trial while continuing the collaboration of OBI-3424 with partners
1.Date of occurrence of the event:2024/03/11 2.Company name: OBI Pharma, Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office 4.Reciprocal shareholding ratios: NA 5.Cause of occurrence: Following …